
Information on ABAT
Information on ABAT Certification Examination
The American Academy of Clinical Toxicology established the American Board of Applied Toxicology (ABAT) to provide special recognition to practitioners of clinical toxicology who demonstrate exceptional knowledge, experience, and competence. ABAT exists as a self-governing entity whose membership consists solely of all current Diplomates of the ABAT. ABAT is governed by a Board of Directors elected by ABAT membership from among its Diplomates.
All ABAT functions are undertaken in accordance with ABAT bylaws and the bylaws of AACT, these bylaws and all regulations and procedures promulgated by ABAT. ABAT is a not-for-profit organization. No member of ABAT receives or derives any profit from the operation of ABAT and no part of the net income of ABAT benefits any individual member. ABAT is not involved in authorizing or designating any political lobby action. The principal office of ABAT is usually established in the city of the residence of the President.
James B. Mowry, PharmD, FAACT, DABAT
President
Thomas E. Kearney, PharmD, DABAT
Vice-President
Karen E. Simone, PharmD, DABAT
Secretary-Treasurer
Elizabeth J. Scharman, PharmD, FAACT, BCPS, DABAT
Past-President
Lee Cantrell, PharmD, DABAT
Daniel J. Cobaugh, PharmD, DABAT
Cynthia L. Morris-Kukoski, PharmD, DABAT
Robert Palmer, PhD, DABAT
Greene Shepherd, PharmD, DABAT
Henry A. Spiller, DABAT
ABAT was created as a not-for-profit organization for the unique purpose of fostering the development of clinical toxicology among the non-physician, non-veterinarian members of the American Academy of Clinical Toxicology by:
Advancing the science, study and practice of clinical toxicology;
Improving the quality of clinical toxicology consultation available to the public;
Establishing and maintaining standards of excellence for non-physician practitioners by developing and administering examinations, as well as other criteria, for the certification and recertification of these practitioners in clinical toxicology;
Granting certificates and other forms of recognition to professionals who demonstrate exceptional ability in clinical toxicology and;
Maintaining a registry of ABAT Diplomates and, upon request, furnishing lists of ABAT Diplomates to the public, governmental agencies, health care professionals, and educational institutions.
James B Mowry, PharmD, FAACT, DABAT
President
c/o Indiana Poison Center
I-65 @ 21st Street
Indianapolis, IN 46206-1367
Phone: (317)962-2329
Fax: (317)962-5825 or 317-962-2337
E-mail: jmowry@clarian.org
Thomas E Kearney, PharmD, DABAT
Vice-President
c/o California Poison Control System, San Francisco
951 Calle Verde
Martinez, CA 94553
Phone: (415)502-6001
Fax: (415)502-6012
E-mail: pcctk@calpoison.org
Karen E Simone, PharmD, DABAT
Secretary
c/o Northern New England Poison Center
22 Bramhall Street
Portland, ME 04102
Phone: (207)662-7221
Fax: (207)662-5941
E-mail: simonk@mmc.org
Obtaining an application for American Board of Applied Toxicology Certification Examination
Thank you for your interest in the American Board of Applied Toxicology certification examination. The following information will acquaint the prospective applicant with some basic introductory guidelines utilized by ABAT to assess applications. If the applicant meets these qualifications, the applicant is invited to submit an application that will be reviewed in detail by the ABAT Credentialing Committee to ascertain final credentialing status. You must be credentialed to sit for the ABAT Certification Examination. A link to a downloadable application follows the guidelines.
Applicants must meet the following initial criteria to become a candidate for examination:
Because the American College of Medical Toxicology and the American Board of Veterinary Toxicology are responsible for certification in their respective areas, applicants holding the Doctor of Medicine, Doctor of Osteopathy, or Doctor of Veterinary Medicine degree are not eligible to sit for the ABAT examination.
Credentialing Committee Review
Following receipt of the completed application and application fee, the candidate's submission is reviewed by the Credentialing Committee. The Committee uses a standardized credential review document among the application reviewers. A formal letter from the President of ABAT will inform the candidate of the committee's decision, and if required, will list areas of improvement the committee felt would allow the candidate to successfully pass credential review on a subsequent submission. Once credentialed, an applicant must take the exam within two examination cycles.
Application Fees
A combined application and testing fee of $400, made payable to the American Board of Applied Toxicology, must accompany the application. If credentialing is denied for any reason, the $300 examination fee will be refunded.
Click here for ABAT Certification Examination Application (MSWord97 format)
Application Deadlines
The deadline for submitting your electronic application is March 1. The paper application and accompanying check for application/examination fees are due March 5.
Application Questions
If you have any questions or problems, please contact the Credentialing Committee Chair at the email address or phone number listed below:
Greene Shepherd, PharmD, DABAT |
Chair, Credentialling Committee |
Medical College of Georgia |
Clinical Pharmacy Program |
1120 15th Street, CJ-1020 |
Augusta, Georgia 30912 |
Phone: 706-721-4250 |
Fax: 706-721-3994 |
E-mail: jshepherd@mcg.edu |
Only those individuals who are credentialled to take the ABAT certification examination may do so. Credentialled applicants must take the examination within two examination cycles. ABAT is committed to providing an examination once per year, but may elect to skip a year if not enough applicants are ready to sit for the exam. A decision is made on or before May 15th of the fall preceding the next examination session whether to proceed with the examination process for that year. The examination is prepared acording to a table of specifications. The examination is given over two days prior to the start of the NACCT meeting. The first day/session involves a written response to case scenarios or situations that would assess the applicant's problem solving skills. The second day/session is comprised of a 100-150 multiple choice answer examination. The Board of Directors grade all examinations. The examinee will usually hear from the President within 4-6 weeks after the close of the NACCT meeting on the results of the examination. A study guide may guide preparation for the examination.